Free Trial

Hyperfine Q1 2023 Earnings Report

Hyperfine logo
$0.96 -0.02 (-2.09%)
As of 01/21/2025 04:00 PM Eastern

Hyperfine EPS Results

Actual EPS
-$0.17
Consensus EPS
-$0.16
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A

Hyperfine Revenue Results

Actual Revenue
$2.64 million
Expected Revenue
$2.20 million
Beat/Miss
Beat by +$440.00 thousand
YoY Revenue Growth
N/A

Hyperfine Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

Hyperfine Earnings Headlines

NeuroPace appoints Scott Huennekens to board
Hyperfine announces new distribution partnerships in EMEA
The #1 Stock for Trump’s Second Term?
Imagine how much money you could make if you bought all of the top performing stocks during Trump's second term? Well, legendary investor Louis Navellier's stock rating system... Gave a buy rating to ALL of the top 30 performing stocks in the S&P 500 index of Trump's first term...
See More Hyperfine Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hyperfine? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hyperfine and other key companies, straight to your email.

About Hyperfine

Hyperfine (NASDAQ:HYPR), a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

View Hyperfine Profile

More Earnings Resources from MarketBeat